<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0191797.ref034" class="ref">
 <label class="label">34</label>
 <mixed-citation publication-type="journal" class="mixed-citation">
  <name class="name">
   <surname class="surname">Droppa-Almeida</surname>
   <given-names class="given-names">D</given-names>
  </name>, 
  <name class="name">
   <surname class="surname">Vivas</surname>
   <given-names class="given-names">WLP</given-names>
  </name>, 
  <name class="name">
   <surname class="surname">Kelly</surname>
   <given-names class="given-names">K</given-names>
  </name>, 
  <name class="name">
   <surname class="surname">Silva</surname>
   <given-names class="given-names">O</given-names>
  </name>, 
  <name class="name">
   <surname class="surname">Rezende</surname>
   <given-names class="given-names">AFS</given-names>
  </name>, 
  <name class="name">
   <surname class="surname">Simionatto</surname>
   <given-names class="given-names">S</given-names>
  </name>, 
  <etal class="etal">et al</etal>
  <article-title class="article-title">Recombinant CP40 from 
   <italic class="italic">Corynebacterium pseudotuberculosis</italic> confers protection in mice after challenge with a virulent strain
  </article-title>. 
  <source class="source">Vaccine</source>. 
  <year class="year">2016</year>;
  <volume class="volume">34</volume>: 
  <fpage class="fpage">1091</fpage>â€“
  <lpage class="lpage">1096</lpage>. 
  <comment class="comment">doi: 
   <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.vaccine.2015.12.064" class="ext-link" xmlns:xlink="http://www.w3.org/1999/xlink">10.1016/j.vaccine.2015.12.064</ext-link>
  </comment>
  <?supplied-pmid 26796140?>
  <pub-id pub-id-type="pmid" class="pub-id">26796140</pub-id>
 </mixed-citation>
</ref>
